Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

CSE:PHRM - Post Discussion

Pharmather Holdings Ltd > FDA Approval !!! Imminent..Not a question of "IF" But "WHEN"
View:
Post by TheLandedEagles on Jun 01, 2024 10:30am

FDA Approval !!! Imminent..Not a question of "IF" But "WHEN"

My take is...we get that approval between now and that new goal date. No question.. when that happens, the share price will move expediously to much higher levels. My guess, we may see over $1 dollar...plus. Company has a very low share count out 88mm shares or so. CEO owns close to 20%, being over 15.5 mm shares and has only been accumulating for the last 2-3 years..plus other things to consider...share price had hit the highs of over $1.20 at one point and they did their last financing at close to .66 cents, and has large amounts of warrants to be exercisable at .80 cents, bringing in much cash close to $14mm into the treasury...All good here!!... this is a multi-bagger, in my opinion. Im holding strong and accumulating at these low prices. To many positive catalyst here , that can propel share price..many products and trials, and the possible spin-out of their subsidary...I can only see positive things and events to occure...barring any unforeseeable occurence, can't see any currently....Large holder, and anticipating to be rewarded here big time...Good luck to all holding. Only time will tell of coarse...Would encourage holders to set their exit strategy as well...maybe $ 1.60 in the short run...who knows, highly possible....These low share prices are going to be history and will be never seen again..My Opion Only!!!
Comment by Sailormark on Jun 03, 2024 11:44pm
With the  little amount of outstanding shares and trading in Canada and the US I am thinking with news and some euphoria this one will run up past $3.00 and quickly.  Just my POV
Comment by TheLandedEagles on Jun 04, 2024 12:29pm
We can only hope and pray it does do like you say. All valid points, should it do and climb along these price points we have mentioned...DON"T GET GREEDY!!!..Set an exit strategy and do not sway from it...BUT, as we all know Human Nature and behavior , Yes ..Greed will get the best of us at the end...lets hope for the best, we need to first get well over that $1 / share mark...then everyone ...more  
Comment by TheLandedEagles on Jun 04, 2024 12:39pm
My current expection is, prior to FDA approval we do get...a News Release to announce a Partnership/Collaboration/Agreement with a high profile Pharma company to joint-venture into this highly scalable / revenue model with PharmaTher.....and the rest will prove of all right with this Pharma Play...Lets pray for all to materialize and also for the benefit of humanity...in treating this highly ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities